Pfizer’s Subsidiary Biohaven Settles for Nearly $60M Over Speaker Programs: Complaint included Significant Open Payments Under Reporting Read more
Navigating the Future of Healthcare Compliance: Transparency, Aggregate Spend & HCP Engagement Forum Read more
Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open Payments Reporting for 2023, Impact of Life Science Compliance, HHS-OIG revision of compliance guidance, and US Final Regulation for Drug Price Negotiations Read more
First-of-its-Kind Study Compares Industry Payments Made to Physicians, Advanced Practice Clinicians Read more
Financial Incentives from Pharmaceutical Companies Resulted in Greater Number of Branded Prescriptions Read more
